C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
Open Access
- 1 December 1984
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 160 (6) , 1640-1655
- https://doi.org/10.1084/jem.160.6.1640
Abstract
C3b [complement component 3b] was covalently linked to [human] IgG via a hydroxylamine-sensitive bond between the C3b .alpha. chain and sites predominantly, but not exclusively, located in the IgG H chain. This C3b species displays relative resistance to inactivation by factors H and I when compared with free C3b. This resistance appears to be due entirely to reduced affinity of C3b-IgG for factor H. Resistance to inactivation is not conferred on C3b by binding to another serum glycoprotein of similar size, ceruloplasmin, and may be a special property of IgG. C3b-IgG demonstrates an enhanced capacity to consume serum C3 relative to C3b. These alterations of the behavior of C3b when bound to IgG may in part explain the augmentation of alternative pathway activity by IgG. In addition, IgG-induced protection of C3b might influence both complement-mediated killing and phagocytosis of bacteria, as well as modify the in vivo handling of IgG-containing soluble immune complexes.This publication has 27 references indexed in Scilit:
- Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.The Journal of Immunology, 1984
- Interaction of C3 and C3b with immunoglobulin GMolecular Immunology, 1983
- Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cells.The Journal of Immunology, 1983
- Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans.Proceedings of the National Academy of Sciences, 1981
- The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serumBiochemical Journal, 1981
- Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.The Journal of Experimental Medicine, 1980
- Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyteThe Journal of Experimental Medicine, 1980
- The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.The Journal of Experimental Medicine, 1980
- The physiological breakdown of the third component of human complementMolecular Immunology, 1980
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977